{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:08:26Z","timestamp":1779174506774,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To characterize choroidal amyloid angiopathy (CAA) using late-phase indocyanine green angiography (ICGA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a multicenter retrospective observational case series on patients with transthyretin (ATTR) and AL amyloidosis who underwent ICGA. The timing of hyperfluorescence and longitudinal changes were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Thirty-two patients (27 with ATTR and 5 with AL) with mean age of 58.9 \u00b1 17.4 years were included. Hyperfluorescent spots in the very late phases of ICGA, corresponding to CAA, were observed in 49 of 55 eyes (89%). The median time to maximal staining was 672 (95% confidence interval, 644\u2013752) seconds, which was significantly later than the initial staining (503 [95% confidence interval, 447\u2013521], <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001; Wilcoxon signed rank test). In seven patients with ATTR amyloidosis who underwent follow-up of ICGA, the CAA was stable in two patients and improved in five patients during treatment. However, 3 patients (43%) had worsening vitreous opacities in both eyes, and 4 patients (57%) developed secondary open-angle glaucoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Most patients with amyloidosis were found to have CAA on ICGA. Up to 12.5 minutes is required for maximal ICG staining. Choroidal amyloid angiopathy improved in most patients with systemic treatment and may serve as a marker of systemic disease status.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003551","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T10:04:39Z","timestamp":1655287479000},"page":"1989-1994","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["CHOROIDAL AMYLOID DEPOSITION"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-4778","authenticated-orcid":false,"given":"Fukutaro","family":"Mano","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Kindai University Faculty of Medicine, Osakasayama, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yonekawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wills Eye Hospital, Jefferson Kimmel Medical School, Philadelphia, Pennsylvania;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kakihara","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Fortun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bascom Palmer Eye Institute, Palm Beach Gardens, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Vita Salute San Raffaele, Milan, Italy; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Vita Salute San Raffaele, Milan, Italy; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kindai University Faculty of Medicine, Osakasayama, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Hematology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wills Eye Hospital, Jefferson Kimmel Medical School, Philadelphia, Pennsylvania;"},{"name":"Ophthalmology, and"},{"name":"Molecular Medicine, Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando","year":"2005","journal-title":"Arch Neurol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13506120400015580","article-title":"A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy","volume":"11","author":"Kawaji","year":"2004","journal-title":"Amyloid"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2169\/internalmedicine.49.3355","article-title":"A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation","volume":"49","author":"Kono","year":"2010","journal-title":"Intern Med"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2017.09.001","article-title":"Ocular manifestations of familial transthyretin amyloidosis","volume":"183","author":"Reynolds","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.121.3.351","article-title":"Secondary glaucoma in patients with familial amyloidotic polyneuropathy","volume":"121","author":"Kawaji","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/13506129.2015.1015678","article-title":"Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases","volume":"22","author":"Beir\u00e3o","year":"2015","journal-title":"Amyloid"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"78","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archophthalmol.2009.390","article-title":"Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients","volume":"128","author":"Hara","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00006982-199212030-00003","article-title":"Digital indocyanine green videoangiography and choroidal neovascularization","volume":"12","author":"Yannuzzi","year":"1992","journal-title":"Retina"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2018.05.023","article-title":"Angiographic signatures of the predominant form of familial transthyretin amyloidosis (Val30Met Mutation)","volume":"192","author":"Rousseau","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2005.05.028","article-title":"Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C","volume":"112","author":"Kawaji","year":"2005","journal-title":"Ophthalmology"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0021-5155(02)00626-3","article-title":"Choroidal vascular lesions identified by ICG angiography in a case of familial amyloidotic polyneuropathy","volume":"47","author":"Kojima","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICB.0000000000000215","article-title":"Multimodal imaging of the retina and choroid in systemic amyloidosis","volume":"9","author":"Roybal","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/IAE.0000000000002961","article-title":"Association between choroidal characteristics and systemic severity in amyloidosis","volume":"41","author":"Mano","year":"2021","journal-title":"Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/lt.21395","article-title":"Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation","volume":"14","author":"Tsuchiya","year":"2008","journal-title":"Liver Transpl"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10384-020-00753-0","article-title":"Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy","volume":"64","author":"Kakihara","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/s41598-020-62559-x","article-title":"Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis","volume":"10","author":"Kakihara","year":"2020","journal-title":"Sci Rep"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","article-title":"A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation","volume":"77","author":"Ando","year":"2004","journal-title":"Transplantation"},{"key":"R21-20250607","first-page":"497","article-title":"The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye","volume":"31","author":"Cavallaro","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.exer.2005.02.003","article-title":"Transthyretin synthesis in rabbit ciliary pigment epithelium","volume":"81","author":"Kawaji","year":"2005","journal-title":"Exp Eye Res"},{"key":"R23-20250607","first-page":"489","article-title":"Distribution of transthyretin in the rat eye","volume":"31","author":"Dwork","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/IAE.0000000000003378","article-title":"Choroidal involvement in hereditary transthyretin amyloidosis patients","volume":"42","author":"Marta","year":"2022","journal-title":"Retina"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Fyfe","year":"2018","journal-title":"N Engl J Med"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/13506129.2018.1554563","article-title":"Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis","volume":"26","author":"Buxbaum","year":"2019","journal-title":"Amyloid"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:03:51Z","timestamp":1749319431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003551"}},"subtitle":["A Multicenter Study of Amyloid Lesions Identified in Late Indocyanine Green Angiography"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003551","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}